Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Nancy McKinney who wrote (794)	7/19/1998 11:35:00 AM
From: Janice Shell	Read Replies (1) \| Respond to of 4028

...solid research into the foundations of anti-ageing IS a breakthrough. 1. What proof do you have that CYGS's research is "solid"? 2. My understanding in any case is that the technology that CYGS hopes to sell wasn't developed by them: In April 1997, CSI licensed technology and began perfecting the patent for their TeloVector(TM) designed to synthesize sequence specific single strands of DNA (ssDNA) in cells (in vivo) to repair telomere ends shortened during cell division (mitosis). biz.yahoo.com and This in vivo expression of single-stranded DNA (ssDNA) that is complementary to an RNA template encoded in a vector was accomplished under a sponsored research agreement by CSI... CSI holds the patent rights of this and related technology developed under the sponsored research agreement. although the press release in question bears the title: CSI Researchers Express ssDNA in Vivo. biz.yahoo.com 3. This kind of research is currently being engaged in by dozens of biotech firms.

To: Nancy McKinney who wrote (794)	7/19/1998 6:49:00 PM
From: Patricia Trinchero	Read Replies (1) \| Respond to of 4028

It may be marketable as a research tool before it's used clinically. If it is proven that this genetically engineered virus is capable of delivering genetic codes to individual cells, then scientists will be wanting to use it. Many companies are discovering the genetic codes to many, many cell characteristics but they have no way of introducing these codes into the cells. This virus is a possible vector(means of transfer)for these many different codes. Scientists can introduce genetic codes into live cells that are grown in tissue culture, but they cannot( to my knowledge) introduce these codes into very specific cells that are part of a complex organism(us!) Although it's a ways from being introduced into humans, animal trials would be possible. Pat T.